TPD & Induced Proximity Summit Leaderboard
  • Thursday, July 2, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 270

Author

Pharma Journalist 8906 posts 0 comments

CHMP Recommends Approval of Lilly and Incyte’s OLUMIANT (baricitinib) as the First and Only…

May 23, 2022
Eli Lilly and Company and Incyte announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for OLUMIANT …
Read More...

PURIFY’22 Takes Chromatography Purification Notches Higher; Industry Rallies Around this Mega Event

May 20, 2022
The mega PURIFY’22 held on 7th April, 2022 at ITC Kohenur, Hyderabad can be summed up as 22 globally acclaimed speakers, addressing 223 delegates who converged from 26 cities across 80…
Read More...

Sinclair Pharma Partners with Vanguard Aesthetics to Launch Silhouette Soft in Malaysia

May 20, 2022
Sinclair Pharma, a global pharmaceutical brand providing aesthetic dermatology and collagen solutions is collaborating exclusively with Vanguard Aesthetics to bring the Silhouette Soft…
Read More...

Ascentage Pharma Announces Preclinical Data Demonstrating Olverembatinib’s Therapeutic…

May 19, 2022
Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that a new…
Read More...

Laekna Therapeutics Raises $61 Million in Series D financing

May 19, 2022
Laekna Therapeutics, a clinical-stage global biotechnology company dedicated to developing next generation medicines to treat cancer and liver diseases, announced that it has raised $61…
Read More...

Tonix Pharmaceuticals Extends Research Collaboration with the University of Alberta to Develop…

May 18, 2022
Tonix Pharmaceuticals Holding Corp. announced it has entered into a license agreement and extended a research collaboration with the University of Alberta, a leading Canadian research…
Read More...

PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with…

May 18, 2022
PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced a multi-year collaboration with the National Institutes of Health to develop…
Read More...

SwanBio Therapeutics Announces $56 Million Series B Financing to Advance Novel Gene Therapies for…

May 18, 2022
SwanBio Therapeutics, a gene therapy company advancing adeno-associated virus (AAV)-based therapies for the treatment of devastating, inherited neurological conditions, today announced…
Read More...

AstraZeneca signs licence agreement with RQ Biotechnology for monoclonal antibodies against COVID-19

May 18, 2022
AstraZeneca has entered into a licence agreement with RQ Biotechnology Ltd (RQ Bio) for a portfolio of early-stage monoclonal antibodies (mAbs) targeted against SARS-CoV-2, the virus…
Read More...

Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19…

May 18, 2022
Pfizer Inc. and BioNTech SE announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization (EUA) to include a booster dose after completion of the primary…
Read More...
Prev Next
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Zymeworks to Acquire Theravance Biopharma in $929 Million Deal
  • EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia
  • Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal
  • AstraZeneca, YMCA Launch National Cancer Education Partnership
  • Antares, Novartis Partner on Cancer Drug Discovery

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.